First Annual SBS China Conference will bring together pharmaceutical Industry experts and local R&D leaders in Shanghai
DANBURY, Conn., July 26 /PRNewswire-USNewswire/ -- The Society for Biomolecular Sciences (SBS), now officially Biomolecular Sciences Section (BSS) of the Society for Laboratory Automation and Screening (SLAS) is pleased to announce an exceptional line-up of keynote speakers as part of the First Annual SBS China Conference Innovation in Drug Discovery: Science & Technology, December 7- 9, 2010, at the Pudong Shangri-La Hotel in Shanghai, China.
"The speaker list is outstanding, with many pharmaceutical industry experts, a number of past SBS presidents, and a few local R&D leaders," said Conference Committee Chair, Zhong Zhong, Ph.D.
On Wednesday, December 8, Jeff W. Paslay, Ph.D., Pfizer, USA will present SBS and 20 Years of Drug Discovery, and Christopher A. Lipinski, Ph.D., Melior Discovery, USA, will present Drug Discovery and Medicinal Chemistry: Rules and Filters and Their Sensible Use.
On Thursday, December 9, Melvin Reichman, Ph.D., Lankenau Institute for Medical Research, USA, will present Revolution and Harmony for Pharmaceutical R&D in Academia and Pharma, and Kiaxian Chen, Ph.D., Shanghai Institute of Materia Medica, China, will present Drug Discovery in China.
"The First Annual SBS China Conference could not come at a better time since China is emerging as an important player in a new era of pharmaceutical research and development," said China Conference keynote speaker Melvin Reichman, Ph.D. "The best way to build strong bridges between drug discovery scientists in the West with those in the East is for SBS to bring us together for this premier conference in Shanghai."
In addition to intensive scientific sessions and networking events, this meeting will be complemented by a vendor exhibition showcasing the latest innovations in drug discovery technology. For more information on the First Annual SBS China Conference or to register, visit the SBS website at www.sbsonline.org/china.
The Society for Laboratory Automation and Screening (SLAS) is a new non-profit scientific organization uniting the Society for Biomolecular Sciences (SBS) and the Association for Laboratory Automation (ALA). The SLAS mission is to be the preeminent global organization providing forums for education and information exchange and to encourage the study of, improve the science and practice of, laboratory automation and screening. Watch for further information about the official launch of SLAS and our new, comprehensive website later this year. For additional information, please visit www.sbs-alamerger.org.
Headquartered in Danbury, CT, the Society for Biomolecular Sciences serves as a section of SLAS, dedicated to drug discovery and its related disciplines. SBS was founded in 1994 to provide a forum for global education and information exchange among professionals in the chemical, pharmaceutical, biotech, and agrochemical industries. SBS members represent many of the largest and most influential research institutes, universities and pharmaceutical companies in the world, including the National Cancer Institute, University of California, Berkeley, Harvard University, government agencies and organizations, and most major companies involved in drug discovery.
Contact Information SBS Media Relations SLAS Media Relations Anne Cox Anne O'Day +1.203.743.1336 x105 +1.630.305.0003 x385 [email protected] [email protected]
SOURCE Society for Biomolecular Sciences